Our priority is to understand how we can reduce the impact of COVID-19 on the health and wellbeing of children and the community now and into the future.

Happy kids at school

At Murdoch Children’s Research Institute (MCRI), we recognise the difficulties parents have faced when supporting children and adolescents during lockdowns and isolation. Over the last few years, our children and young people experienced huge restrictions in their capacity to socialise, learn, play and develop.

Our ongoing response to COVID-19 draws upon the breadth and depth of our COVID-19 research and our deep understanding of children, young people, families and their communities. We strive to improve the global understanding of the effects of the virus on children.

How we're working to fight COVID-19

child with parent

Our COVID-19 children's research program

Children are at the heart of everything we do. Our COVID-19 children's research program is creating the robust evidence we need to understand, treat and prevent COVID-19, and its impact on children.

Explore COVID-19 children's research
Three children smiling

Research briefs

Read our research findings and discover how this research can inform adaptive health policy and practice.

View all research briefs

 

COVID-19 Population Immunity Webinar 2022

Hear information on COVID-19 immunity from local and international guest speakers.

In this webinar, hosted in November 2022, we discussed the effectiveness and immunity derived from prior COVID-19 infection, from vaccination alone, and from a combination of prior infection and vaccination (hybrid immunity) to understand our population’s immunity and what the future might hold for the COVID-19 vaccination program.

Presenters

  • Professor Fiona Russell, Murdoch Children's Research Institute
  • Professor Katie Flanagan, Head of Infectious Diseases, Launceston General Hospital, Tasmania
  • Dr Niklas Bobrovitz, Research Lead, SeroTracker, O'Brien Institute of Public Health, University of Calgary

In this webinar, hosted in November 2022, we discussed the effectiveness and immunity derived from prior COVID-19 infection, from vaccination alone, and from a combination of prior infection and vaccination (hybrid immunity) to understand our...

In this webinar, hosted in November 2022, we discussed the effectiveness and immunity derived from prior COVID-19 infection, from vaccination alone, and from a combination of prior infection and vaccination (hybrid immunity) to understand our population’s immunity and what the future might hold for the COVID-19 vaccination program.

Presenters

  • Professor Fiona Russell, Murdoch Children's Research Institute
  • Professor Katie Flanagan, Head of Infectious Diseases, Launceston General Hospital, Tasmania
  • Dr Niklas Bobrovitz, Research Lead, SeroTracker, O'Brien Institute of Public Health, University of Calgary
Child smiling

Your support can help accelerate research and scientific breakthroughs, and the development of life-saving cures and better, affordable treatments for children.

Help make a difference today